Hamman-Rich syndrome historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (7 intermediate revisions by the same user not shown) | |||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
In 1935, Hamman and rich first described cases with rapidly progressing [[Interstitial lung disease|pulmonary fibrosis]] of unknown [[etiology]]. After that, the eponym, [[Hamman-Rich syndrome]] have been used to describe [[idiopathic pulmonary fibrosis]]. In 1975, Liebow came up with [[classification]] to distinguish between pulmonary fibrosis and idiopathic interstitial lung diseases. In 1986, Katzenstein used the term [[Hamman-Rich syndrome|acute interstitial pneumonitis]]. Further studies helped to differentiate [[Hamman-Rich syndrome|acute interstitial pneumonitis]] from pulmonary fibrosis. | |||
==Historical Perspective== | ==Historical Perspective== | ||
The historical perspective of the [[Hamman-Rich syndrome|acute interstitial pneumonitis]] is as follows: | |||
=== | *In 1935, the two pathologists Hamman and Rich have reported four cases of very rapidly progressing [[Interstitial lung disease|pulmonary fibrosis]] with identical [[Histology|histologic appearances]].<ref name="pmid5763321">{{cite journal |vauthors=Parr LH |title=Hamman-Rich syndrome. Idiopathic pulmonary interstitial fibrosis of the lung |journal=J Natl Med Assoc |volume=61 |issue=1 |pages=8–12 |date=January 1969 |pmid=5763321 |pmc=2611586 |doi= |url=}}</ref> | ||
*[ | *After this, the eponym, [[Hamman-Rich syndrome]] used to describe the cases of progressive [[Interstitial lung disease|pulmonary fibrosis]] of no identifiable etiology. | ||
*After that [[Hamman-Rich syndrome]] used synonymously with [[idiopathic pulmonary fibrosis]]. | |||
* | *In 1975, to avoid confusion between idiopathic pulmonary fibrosis and idiopathic interstitial lung diseases, Liebow proposed a classification. | ||
* | **Classification includes five distinct entities: | ||
*In [ | ***[[Usual interstitial pneumonia]] | ||
***[[Desquamative interstitial pneumonia]] | |||
== | ***Bronchiolitis obliterans with interstitial pneumonia | ||
* | ***Lymphoid interstitial pneumonia | ||
***Giant cell interstitial pneumonia. | |||
**He described more rapidly progressing pulmonary fibrotic diseases including [[Hamman-Rich syndrome]] under [[usual interstitial pneumonia]]. | |||
* | *In 1986, eight cases of acute respiratory failure of unknown [[etiology]], showing organizing diffuse alveolar damage on histopathological specimens were reported by Katzenstein.<ref name="pmid9563754">{{cite journal |vauthors=Katzenstein AL, Myers JL |title=Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification |journal=Am. J. Respir. Crit. Care Med. |volume=157 |issue=4 Pt 1 |pages=1301–15 |date=April 1998 |pmid=9563754 |doi=10.1164/ajrccm.157.4.9707039 |url=}}</ref> | ||
**They likened the disease to the acute interstitial fibrosis first reported by Hamman and Rich in 1935. | |||
== | **Then he proposed the term [[Hamman-Rich syndrome|acute interstitial pneumonitis]] to differentiate from the [[acute respiratory distress syndrome]], which has same [[pathology]] of organizing diffuse alveolar damage. | ||
* Olson et al reviewed three of Hamman and Rich’s original cases. They confirmed the histopathologic lesion in those cases is diffuse alveolar damage. Those studies helped in establishing both [[Hamman-Rich syndrome|acute interstitial pneumonitis]] and [[Hamman-Rich syndrome]] have same clinical and pathogical presentations and helped to distinguish [[Interstitial lung disease|pulmonary fibrosis]] from [[Hamman-Rich syndrome|acute interstitial pneumonitis.]] | |||
== | *In 2000, the American Thoracic Society and the European Respiratory Society international consensus published a statement stating acute interstitial pneumonitis is distinct from pulmonary fibrosis.<ref name="pmid11790668">{{cite journal |vauthors= |title=American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 |journal=Am. J. Respir. Crit. Care Med. |volume=165 |issue=2 |pages=277–304 |date=January 2002 |pmid=11790668 |doi=10.1164/ajrccm.165.2.ats01 |url=}}</ref> | ||
==References== | ==References== | ||
Latest revision as of 15:56, 30 March 2018
|
Hamman-Rich syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hamman-Rich syndrome historical perspective On the Web |
|
American Roentgen Ray Society Images of Hamman-Rich syndrome historical perspective |
|
Risk calculators and risk factors for Hamman-Rich syndrome historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chandrakala Yannam, MD [2]
Overview
In 1935, Hamman and rich first described cases with rapidly progressing pulmonary fibrosis of unknown etiology. After that, the eponym, Hamman-Rich syndrome have been used to describe idiopathic pulmonary fibrosis. In 1975, Liebow came up with classification to distinguish between pulmonary fibrosis and idiopathic interstitial lung diseases. In 1986, Katzenstein used the term acute interstitial pneumonitis. Further studies helped to differentiate acute interstitial pneumonitis from pulmonary fibrosis.
Historical Perspective
The historical perspective of the acute interstitial pneumonitis is as follows:
- In 1935, the two pathologists Hamman and Rich have reported four cases of very rapidly progressing pulmonary fibrosis with identical histologic appearances.[1]
- After this, the eponym, Hamman-Rich syndrome used to describe the cases of progressive pulmonary fibrosis of no identifiable etiology.
- After that Hamman-Rich syndrome used synonymously with idiopathic pulmonary fibrosis.
- In 1975, to avoid confusion between idiopathic pulmonary fibrosis and idiopathic interstitial lung diseases, Liebow proposed a classification.
- Classification includes five distinct entities:
- Usual interstitial pneumonia
- Desquamative interstitial pneumonia
- Bronchiolitis obliterans with interstitial pneumonia
- Lymphoid interstitial pneumonia
- Giant cell interstitial pneumonia.
- He described more rapidly progressing pulmonary fibrotic diseases including Hamman-Rich syndrome under usual interstitial pneumonia.
- Classification includes five distinct entities:
- In 1986, eight cases of acute respiratory failure of unknown etiology, showing organizing diffuse alveolar damage on histopathological specimens were reported by Katzenstein.[2]
- They likened the disease to the acute interstitial fibrosis first reported by Hamman and Rich in 1935.
- Then he proposed the term acute interstitial pneumonitis to differentiate from the acute respiratory distress syndrome, which has same pathology of organizing diffuse alveolar damage.
- Olson et al reviewed three of Hamman and Rich’s original cases. They confirmed the histopathologic lesion in those cases is diffuse alveolar damage. Those studies helped in establishing both acute interstitial pneumonitis and Hamman-Rich syndrome have same clinical and pathogical presentations and helped to distinguish pulmonary fibrosis from acute interstitial pneumonitis.
- In 2000, the American Thoracic Society and the European Respiratory Society international consensus published a statement stating acute interstitial pneumonitis is distinct from pulmonary fibrosis.[3]
References
- ↑ Parr LH (January 1969). "Hamman-Rich syndrome. Idiopathic pulmonary interstitial fibrosis of the lung". J Natl Med Assoc. 61 (1): 8–12. PMC 2611586. PMID 5763321.
- ↑ Katzenstein AL, Myers JL (April 1998). "Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification". Am. J. Respir. Crit. Care Med. 157 (4 Pt 1): 1301–15. doi:10.1164/ajrccm.157.4.9707039. PMID 9563754.
- ↑ "American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001". Am. J. Respir. Crit. Care Med. 165 (2): 277–304. January 2002. doi:10.1164/ajrccm.165.2.ats01. PMID 11790668.